ETEC Vaccine Opportunithy
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- W81XWH-20-C-0137
- Agency
- Medical Command Department of the Army, Department of Defense
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- W81XWH-20-C-0137 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- SWE
Notice details come from SAM.gov. Updated .
About this opportunity
This Limited/Sole Source Justification Notice was published by the Department of the Army Medical Command to award a sole source contract to Scandinavian Biopharma Holding AB for the development and delivery of its Etvax multivalent vaccine against Enterotoxigenic Escherichia coli. Market research identified Etvax as the only product currently in Phase II clinical trials capable of rapid delivery to pivotal studies within two years to provide an estimated $14.2 million and two-year savings over alternatives for preventing bacterial diarrhea in military personnel. The contract aims to deliver cGMP manufactured Etvax suitable for pivotal clinical trials with the goal of FDA licensure under contract number W81XWH-20-C-0137 for an unknown amount, awarded on September 25, 2020.
Notice text
The primary objective of this contract shall be delivery of a cGMP manufactured product of quantity and quality that it is suitable and appropriate for use in pivotal clinical studies to demonstrate efficacy against Enterotoxigenic Escherichia coli (ETEC) in adults with the goal of FDA licensure. The objective activities will support a multivalent ETEC vaccine with the long-term goal of preventing bacterial diarrhea in Warfighters.
Awarded contract W81XWH-20-C-0137 to unknown vendor for unknown amount on 2020-09-25.
Attachments
| File | Type | Posted |
|---|---|---|
| W81XWH-20-C-0137 JA ETEC Redacted_Redacted.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity